# Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phosphodiesterase-4-inhibitors-for-the-treatment-of-inflammatory-diseases/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Heng Li,Jianping Zuo,Wei Tang |
| Citations | 572 |
| DOI | 10.3389/fphar.2018.01048 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fphar.2018.01048/pdf |
| OpenAlex ID | https://openalex.org/W2897406695 |
| PMID | 30386231 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Wei Tang](https://scholariq.org/researchers/wei-tang/)

## Paper journal

- [Frontiers in Pharmacology](https://scholariq.org/journals/frontiers-in-pharmacology/)

## Paper primary topic

- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)

## Paper topics

- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.